🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
MCK
NYSE
🇺🇸 US
McKesson Corporation
Healthcare
23Score
DipBuster Score™
$907.99
$13.39 (-1.45%)
Live price · Source: Yahoo
52-Week Position
$683.38
71% of range
$999.00
Beta
0.307
Low vol
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.307
52W High$999.00
52W Low$683.38
DipBuster Brief
Key signals at a glance
Zone: Consider Trimming
Neutral
Mid-Range Position (71% of 52-Week Range)
The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position71% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.307
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at McKesson Corporation (MCK), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-08-10 | Lerman Bradley E | SELL | 301 |
| 2026-08-07 | Srinivasan Ramesh (nmn) | BUY | 368 |
| 2026-07-22 | Hinton James H. | BUY | 277 |
| 2026-07-22 | Doughtie Lynne M | BUY | 277 |
| 2026-07-22 | Gerberding Julie L. | BUY | 277 |
| 2026-07-22 | Martinez Maria | BUY | 277 |
| 2026-07-22 | Lerman Bradley E | BUY | 277 |
| 2026-07-22 | Ozan Kevin M | BUY | 277 |
| 2026-07-22 | Caruso Dominic J | BUY | 277 |
| 2026-07-22 | Dunsire Deborah | BUY | 277 |
Valuation
P/E RatioN/A
Market CapN/A
Beta0.307
Dividend/yrNone
52W High$999.00
52W Low$683.38
52-Week Range
$683.38Now$999.00
71% through annual range
From 52W High−9.1%
From 52W Low+32.9%
📖 Plain English Summary
McKesson Corporation is at 71% of its 52-week range. Beta 0.307 — tends to move less than the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for MCK
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — MCK
Heuristic · balance sheet, insider filings, price data, academic research
McKesson Corporation — DipBuster Score 23/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track McKesson Corporation free
Add MCK to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Freetrade
Simple investing app. Free ISA. UK and US stocks. FCA regulated.
Free share when you fund your account
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
12/25
Momentum & Volume
6/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
2
/100 · NEUTRAL
dip depth
2/25
oversold rsi
0/25
mean reversion
0/15
insider zone
0/25
capitulation
0/10
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 23/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key busi…
Sector
Healthcare
Market
🇺🇸 US
CEO
Brian S. Tyler
Staff
42,300 employees
Website